Abaloparatide/247062-33-5 CAS NO.247062-33-5

FOB Price: USD: 1,000.00-1,000.00 /Gram Get Latest Price
Min.Order: 1 Gram
Payment Terms: T/T,MoneyGram
Available Specifications:
quantity(1-10)Gram1000/Gram1USD

Product Details

Keywords

247062-33-5
Abaloparatide
high purity

Quick Details

ProName: Abaloparatide/247062-33-5
CasNo: 247062-33-5
Molecular Formula: C174H299N56O49
Appearance: white powder
Application: esearch for osteoporosis in postmenopa...
DeliveryTime: 7d
PackAge: Plastic bottle, 0.1 gram/bottle, 1 gra...
Port: Chengdu
ProductionCapacity: 500 Gram/Month
Purity: 98%
Storage: -20
Transportation: FedEx/DHL/EMS or by air.
LimitNum: 1 Gram
Molecular formula: C174H299N56O49

Superiority

Chengdu YoungShe Chemical Co.,Ltd is a dynamic and progressive cosmetic peptides supplier in China. We are dedicating to be a professional, efficient,and reliable partner for global customers on cosmetic peptides. You can select more than 170 kinds of raw cosmetic peptide ingredients here.And we are keeping developing new products and continuously marketing them for sale.Youngshe Chem provide a one-stop service for raw cosmetic peptide ingredients.You will save lots of time ,energy, money and have a very pleasant experience with us.Since Dec,2014,YoungShe group has expanded their business to botanical cosmetic active ingredients and related.

Details

Abaloparatide

Name: abaloparatide

CAS No. :247062-33-5

Sequence: H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-Aib-Lys-Leu-His-Thr-Ala-NH2

Molecular formula: C174H299N56O49

Molecular weight : 3959.65

Purity: >98.0%

Source: synthetic

MSDS and COA: available

Details: Abaloparatide is an analog of human pTHrP (1-34). It is a potent and selective activator of the parathyroid hormone receptor (PTH1R) signaling pathway and can stimulate bone formation with less of the accompanying bone resorption and hypercalcemic effects that can occur with pTH (1-34). Abaloparatide can be used in research for osteoporosis in postmenopausal women who have a high risk of bone fracture.